
TNDM Stock Forecast & Price Target
TNDM Analyst Ratings
Bulls say
Tandem Diabetes Care is expected to continue its strong performance with its diverse workforce and successful PayGo program, providing an opportunity for investors. The launch of its Mobi pump and development of a closed-loop algorithm for its pumps also indicate potential for growth. However, potential risks such as competition and supply chain management should be considered. Overall, the company's potential for long-term growth and current undervalued stock make it an attractive investment opportunity.
Bears say
Tandem Diabetes Care is a player in the insulin pump market that, while having an impressive portfolio of pump offerings and demonstrating strong accuracy with its Control IQ feature, is facing challenges. These challenges include slower-than-expected adoption outside of the US, a need for reimbursement in Type 2 patients, and expected future investment for their upcoming pumps. Furthermore, while the company has set ambitious targets, it remains to be seen whether they can achieve them, given the current competitive and regulatory landscape.
This aggregate rating is based on analysts' research of Tandem Diabetes Care and is not a guaranteed prediction by Public.com or investment advice.
TNDM Analyst Forecast & Price Prediction
Start investing in TNDM
Order type
Buy in
Order amount
Est. shares
0 shares